Name Mirko Beljanski Died 1998 | Education University of Paris | |
 | ||
Books The Regulation of DNA Replication and Transcription | ||
L he ritage scientifique de mirko beljanski
Mirko Beljanski (27 March 1923 – 28 October 1998) was a French-Serbian molecular biologistwho focused on finding a natural cure for Cancer by using Pao pereira and Rauwolfia vomitoria, notable in the latter part of his career for treating French president François Mitterrand with his discoveries.
Contents
- L he ritage scientifique de mirko beljanski
- Complot mondial contre la sant l affaire mirko beljanski
- Career
- Clinical research
- Death
- References
Complot mondial contre la sant l affaire mirko beljanski
Career
Beljanski was born in 1923 in Yugoslavia. He came to France to study, and lived there for the rest of his life. He was married to Monique Lucas, daughter of René Lucas and grand-daughter of Pauline Ramart. He received a PhD in 1948 from the University of Paris. In 1948, he entered the CNRS and worked at the Pasteur Institute in Paris as a researcher in molecular biology. He made several discoveries while studying RNA and DNA. Beljanski was made to leave the Pasteur Institute in 1978, after pursuing research against the advice of the institute, but still continued to publish scientific papers. He was at the Faculty of Pharmacy of Châtenay-Malabry until his retirement in 1988.
In his lifetime, Beljanski published a total of 133 scientific papers, mostly written in French., 2 books and 11 patents.
Beljanski believed he had found antivirals effective against cancer and AIDS. A product made from extracts of the Brazilian Pao pereira tree and called PB100 was claimed to be superior to AZT, which Beljanksi called "real poison". Customers included François Mitterrand (via a homeopath called Philippe de Kuyper).. There was never any evidence that any of the products Beljanski promoted were effective medicine; the French Department of Health accused him of illegally practising medicine in 1991, but he was never tried. In 2002, the European court of human rights ruled that the length of the proceedings against Beljanski was excessive and therefore that France had been violated Beljanski's rights.
Clinical research
Beljanski did several research with small RNA fragments. Beljanski showed Some RNA fragments encourage the formation of platelets and white blood cells. Research showed RNA fragments developed the DNA of healthy cells but not cancer cells.
According to The Beljanski Foundation, In 1994, A clinical trial with the PB-100 was organized at the University Hospital Lapeyronie and published in Deutsche Zeitschrift für Onkologie.
Death
Beljanski died from cancer in Paris on 27 October 1998.